Patent details

EP3093290 Title: MORPHINAN COMPOUNDS

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
EP3093290
WO Application Number:
Type:
European Patent Granted for NL
Status:
Deemed not to be granted according to art. 52.4a or 52.6 ROW
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP16163718.6
WO Publication Number:
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
United States of America (US)
Publications:

Dates

Filing date:
30/04/2008
Grant date:
24/01/2018
EP Publication Date:
16/11/2016
WO Publication Date:
Claims Translations Received Date:
Claims Translation B1 Received Date:
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
24/01/2018
EP B1 Publication Date:
24/01/2018
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
29/04/2028
Lapsed By Expiration Date:
Revocation Date:
Invalidity Date:
24/01/2018
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:

Applicant/holder

From:
24/01/2018
 
 

 

Name:
Concert Pharmaceuticals Inc.
Address:
99 Hayden Avenue, Suite 500, LEXINGTON, MA 02421, United States of America (US)

Inventor

Name:
TUNG, Roger
Address:
Lexington, MA 02420, United States of America (US)

Priority

1

Priority Patent Number:
976044 P
Priority Date:
28/09/2007
Priority Country:
United States of America (US)

2

Priority Patent Number:
916662 P
Priority Date:
08/05/2007
Priority Country:
United States of America (US)

3

Priority Patent Number:
915130 P
Priority Date:
01/05/2007
Priority Country:
United States of America (US)

Classification

IPC or IDT classification:
A61K 31/439; A61P 11/14; C07B 59/00; C07D 471/08;

Publication

Bulletin

1

Bulletin Heading:
VRV
Journal edition number:
23/18
Publication date:
30/05/2018
Description:
Lapse or annulment

2

Bulletin Heading:
EP2
Journal edition number:
05/18
Publication date:
24/01/2018
Description:
European patents granted for the Netherlands

European Patent Bulletin

Issue number:
201804
Publication date:
24/01/2018
Description:
Grant (B1)

Annual Fee

Annual Fee(s) Due Date:
Annual Fee Number:
Last Annual Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Document Description Number of pages File Type